INKT - MiNK Therapeutics, Inc.
10.28
-0.670 -6.518%
Share volume: 6,221
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$10.95
-0.67
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-14-2024 | 03-18-2025 | 05-15-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 6.894 M | 10.324 M | 7.375 M | 5.721 M | 4.267 M | 14.964 M | |
| Current Assets | 5.999 M | 9.474 M | 6.575 M | 4.988 M | 3.580 M | 14.534 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 122.477 K | 61.144 K | 11.195 K | 164.244 K | 108.711 K | 32.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 5.817 M | 9.314 M | 6.328 M | 4.577 M | 3.235 M | 14.281 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 894.992 K | 849.957 K | 799.522 K | 732.929 K | 687.500 K | 429.344 K | |
| Other Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 6.894 M | 10.324 M | 7.375 M | 5.721 M | 4.267 M | 14.964 M | |
| Total liabilities | 27.193 M | 26.900 M | 24.929 M | 25.307 M | 26.059 M | 28.477 M | |
| Total current liabilities | 11.108 M | 10.147 M | 7.399 M | 6.960 M | 12.120 M | 13.434 M | |
| Accounts Payable | 3.487 M | 3.202 M | 2.361 M | 2.728 M | 2.661 M | 3.693 M | |
| Other liabilities | 11.873 M | 12.347 M | 12.918 M | 13.422 M | 13.939 M | 15.043 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 4.212 M | 4.406 M | 4.612 M | 4.925 M | 0.000 | 0.000 | |
| Other liabilities | 11.873 M | 12.347 M | 12.918 M | 13.422 M | 13.939 M | 15.043 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -20.299 M | -16.576 M | -17.554 M | -19.586 M | -21.792 M | -13.513 M | |
| Common stock | 117.297 M | 123.947 M | 124.837 M | 125.227 M | 125.819 M | 141.253 M | |
| Retained earnings | -137.210 M | -139.912 M | -141.719 M | -144.182 M | -146.948 M | -154.074 M |